Here are four takeaways:
1. Mr. Hykes replaces Alex DiNello who has been the company’s CEO since 2011. Mr. DiNello will remain in the company as chief operating officer.
2. Previously, Mr. Hykes served as chairman and CEO of Metavention, a clinical stage medical device company developing interventional therapies for Type 2 diabetes. Mr. Hykes remains chairman of the board of directors at Medavention.
3. Mr. Hykes served as president and CEO of Cameron Health, developer of the first subcutaneous implantable defibrillator prior to taking on his current role. He also spent 16 years at Medtronic holding leadership positions in the cardiac rhythm management, neurological, health valve and cardiac surgery
businesses.
5. Currently, Relievant Medsystems is commercializing the Intracept System, designed to deliver targeted energy into the spine and block transmission of pain signals from the basivertebral nerve.
More articles on devices and implants:
Implanet reports 19% increase in spine revenue for 1st half of 2017: 7 key points
Florida Hospital Nicholson Center installs Titan Medical’s Sport Surgical System: 5 notes
Global spine devices market to soar to $8.4B by 2022 — 9 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
